Skip to main content
. 2022 Aug 14;12:129. doi: 10.1186/s13578-022-00868-6

Table 3.

Approved and investigational drugs targeting PDIs

Target Drug name
PDIA1 Ribostamycin, copper, zinc, artenimol, zinc acetate, zinc chloride, zinc sulfate
CASQ1 Calcium citrate, calcium levulinate, calcium phosphate, calcium phosphate dihydrate
PDIA3 Copper, zinc, zinc acetate, zinc chloride, zinc sulfate
CASQ2 Calcium citrate, calcium phosphate, calcium phosphate dihydrate